Prashant Kohli
Fortuna: 54 887 $ al 31/05/2026
Fortuna: 54 887 $ al 31/05/2026
Prashant Kohli is currently Chief Executive Officer & Director at Grace Therapeutics, Inc. since 2023.
Education history includes an undergraduate degree from Augustana College (Illinois) and an MBA from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GRACE THERAPEUTICS, INC. 0,14 % | 18/07/2025 | 21.357 ( 0,14 % ) | 54 887 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GRACE THERAPEUTICS, INC. | Director Ejecutivo | 04/04/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Designs and develops drug delivery technology and products | Corporate Officer/Principal | 01/08/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Grace Therapeutics, Inc.
Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases | Health Technology |
Augustana College (Illinois)
Augustana College (Illinois) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Designs and develops drug delivery technology and products | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.